Merck · 4 months ago
Senior Principal Scientist, Clinical Research, Neuroscience
Merck is a leading global healthcare company, and they are seeking a Senior Principal Scientist in Clinical Research focused on Neuroscience. The role involves planning and directing clinical research activities, managing clinical trials, and providing scientific leadership across various projects.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Evaluating pre-clinical and translational work for the purpose of generating early clinical development plan and Investigational New Drug applications
Developing clinical development strategies for investigational or marketed Neuroscience drugs that incorporate the latest scientific developments, regulatory requirements, the competitive landscape, and commercial considerations
Planning clinical trials (design, operational plans, settings) based on these clinical development strategies
Monitoring and managing the conduct of ongoing or new clinical trials for investigational or marketed Neuroscience drugs
Analyzing and summarizing the clinical findings from studies to support decisions regarding safety and efficacy as well as new drug applications, clinical study reports, or publication
Participation in internal and joint internal/external research project teams relevant to the development of new compounds, and the further study of marketed compounds; and
Support of business development assessments of external opportunities
Provide support for other therapeutic areas regarding clinical issues related to Neuroscience
Supervise the activities of Clinical Scientists in the execution of clinical studies
Work closely with a cross-functional group of experts in commercialization, regulatory affairs, statistics, and manufacturing to manage clinical development projects; and assist the Vice President in ensuring that appropriate Corporate personnel is informed of the progress of studies of our company and competitors' drugs and internal and external expert opinion on scientific questions relevant to his/her areas of responsibility
Maintaining awareness of scientific developments within his/her area of expertise, in terms of new scientific findings, research methodologies
Identification of scientifically and operationally strong investigators who can assist in the development of our company's investigational and marketed drugs
Establishing communications with prominent clinical investigators in his/her particular field of interest, particularly those who will be willing and able to assist in the evaluation of our company's drugs
Attending appropriate scientific meetings to maintain his or her competency and to maintain awareness of research activities in his/her area of responsibility
Author detailed development documents, presentations, budgets, and position papers for internal and external audiences
Facilitating collaborations with external researchers around the world
Travel on company business about twenty (20) percent of the time to manage future or ongoing clinical research projects
Qualification
Required
Must have experience in industry or senior faculty in academia
Minimum of 3 years of clinical medicine experience
Minimum of 3 -5 years of industry experience in drug development or biomedical research experience in academia
Demonstrated record of scientific scholarship and achievement
A proven track record in clinical medicine and background in biomedical research is essential
Strong interpersonal skills, as well as the ability to function in a team environment, are essential
Preferred
Board Certified or Eligible in Neurology or Psychiatry
Prior specific experience in clinical research and prior publication
Benefits
Medical
Dental
Vision healthcare
Other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
WSJ.com: US Business
2026-01-11
2026-01-11
Company data provided by crunchbase